Chronic pain syndromes have multiple possible causes which are often complex and difficult to identify. However, pain is caused by the perception of pain, which is processed in the sensory cortices. Pain processing can be affected by various factors such as genetics, physical health, or psychological health. The process of pain perception, however, is not dependent on these factors. The brain's pain pathways are relatively simple. Pain perception can be affected by diseases, such as cancer. There is no proof that a disease causes chronic pain but chronic pain is an important sign of illness. Chronic pain affects individuals in all ages. It is the most common symptom for a range of medical conditions.
Almost two million people in the United States are affected by [chronic pain](https://www.withpower.com/clinical-trials/chronic-pain) at any given time, and there appear to be no differences in the prevalence of chronic pain by gender. The impact of chronic pain may be of great societal importance, as measured by the level of work disruption, pain-related disability, pain-related health care utilization, and overall disability.
Patients suffering from chronic non-cancerous pain have higher levels and more severe pain than patients free from pain. The levels and severity of pain decrease significantly during active treatment, most likely because of the reduction of pain sensitivity. This reduction is not explained by the opioid administration. In the light of recent research findings, the issue of the possible existence of persistent pain that will persist during remission needs to be settled.
The common perception is that [chronic pain](https://www.withpower.com/clinical-trials/chronic-pain) is pain that cannot be controlled. Although pain may be difficult to control, our findings demonstrate that there is not always pain out of control. Understanding the cause of this and other pain may broaden treatment options.
Results from a recent paper reveals numerous potentially useful treatments for [chronic pain](https://www.withpower.com/clinical-trials/chronic-pain), but the lack of high quality controlled research restricts assessment as a treatment option for chronic pain. The treatments listed in this review may be of benefit for individual patients by alleviating the experience of pain or distress. They may, however, not be suitable for some people.
The symptoms of [chronic pain](https://www.withpower.com/clinical-trials/chronic-pain) are the same as those of other chronic non-cancer diseases with little or no cure options. To manage chronic pain, it is very important to get the patient to know the pain pattern so that they can start modifying their lifestyle, eating and alcohol habits from eating to alcohol to medication.
e-ss is a safe and feasible device for people when provided in a designated setting, as an alternative to traditional ambulatory care options such as conventional outpatient orthopaedics clinics. Its safety is enhanced by a multispecialty-based integrated team approach, patient coaching and follow-up care post-operatively. The effectiveness and safety of e-ss can improve patient outcomes and encourage access to other health care services. Clinicaltrials.gov N: NCT02238169.
As such, [chronic pain](https://www.withpower.com/clinical-trials/chronic-pain) poses a serious threat to the physical and psychological well being of a person. It is an indicator of much more serious, possibly life threatening, disease such as AIDS and cancer. Chronic pain is not simply a nuisance. It is not easily treatable and is an obstacle to social integration and fulfilling employment. Sufferers often feel they have no real choice but to seek medical and surgical intervention, to which the medical profession should refuse to administer opioids, and refuse to consider the possibility of alternative treatment which may be easier, less painful, and ultimately maybe safer.
There are a small number of common side effects in the smart system (et- ss) group: fatigue, decreased appetite, and insomnia. On the other hand, because we found there is no significant difference between the two treatment arms (et- ss and et-ss) after adjusting for baseline baseline symptoms and the presence or absence of common common side effect in the two treatment groups (et- ss versus et-ss), we found no sign that the presence of the et- ss treatment adds anything useful to the treatment of [chronic pain](https://www.withpower.com/clinical-trials/chronic-pain) and chronic fatigue. Therefore, we would say that et- ss is equally as safe as et- ss and we suggest its use for anyone with chronic fatigue or pain in which mental wellbeing is important.
No new discoveries for treating chronic pain have been made. The lack of evidence supports the hypothesis that chronic pain is caused by a dysfunctional opioid system and that the chronic pain itself is a secondary phenomenon resulting as a side effect of the dysfunction. It is our belief that most chronic pain treatments are overuse and ineffective.
There have been no clinical trials comparing the short term effects of et- ss to placebo. However, the et- ss trial has shown significant prolongation of pain relief compared to placebo, which is very encouraging. The clinical trial is still underway and it is expected to take another 3 years, therefore this treatment cannot be considered as a treatment that will provide quick relief for pain. Long term effects of et- ss are not known. The et- ss study has shown significant prolongation in average of pain from baseline to 12 months compared to placebo. It is expected that et- ss will not provide a long term solution to the pain that is experienced by many patients suffering from chronic pains.
The answer is NOT “NO evidence” and “very limited evidence” but “data”. In my opinion the term “data” is the best explanation for the “NO evidence” of what could be the new craze for “Chronic pain.” However, since there are more cures in the pipeline I feel that the new craze will be short lived. \n